Insider Transactions in Q1 2026 at Bicycle Therapeutics PLC (BCYC)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2026
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,989
-1.74%
|
$65,934
$6.46 P/Share
|
|
Jan 05
2026
|
Alethia Young Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,334
-2.4%
|
$26,004
$6.5 P/Share
|
|
Jan 05
2026
|
Alistair Milnes CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
3,416
-2.44%
|
$20,496
$6.46 P/Share
|
|
Jan 05
2026
|
Michael Charles Ferguson Hannay CHIEF PROD & SUPPLY CHAIN OFF |
SELL
Open market or private sale
|
Direct |
2,367
-2.36%
|
$14,202
$6.45 P/Share
|
|
Jan 05
2026
|
Michael Skynner CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct |
3,266
-1.98%
|
$19,596
$6.46 P/Share
|
|
Jan 05
2026
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,115
-1.65%
|
$6,690
$6.45 P/Share
|
|
Jan 02
2026
|
Robert Charles Swanton |
BUY
Grant, award, or other acquisition
|
Direct |
3,726
+16.24%
|
-
|
|
Jan 02
2026
|
Jose Carlos Gutierrez Ramos |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+22.62%
|
-
|
|
Jan 02
2026
|
Janice Bourque |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+22.62%
|
-
|
|
Jan 02
2026
|
Herve Hoppenot |
BUY
Grant, award, or other acquisition
|
Direct |
3,032
+16.33%
|
-
|
|
Jan 02
2026
|
Gregory Paul Winter |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+4.61%
|
-
|
|
Jan 02
2026
|
Roger D Dansey |
BUY
Grant, award, or other acquisition
|
Direct |
3,032
+16.33%
|
-
|
|
Jan 02
2026
|
Alessandro Riva |
BUY
Grant, award, or other acquisition
|
Direct |
7,380
+27.07%
|
-
|
|
Jan 02
2026
|
Stephen H. Sands |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+26.1%
|
-
|
|
Jan 02
2026
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,325
-1.61%
|
$61,950
$6.8 P/Share
|
|
Jan 02
2026
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
165,000
+20.49%
|
-
|
|
Jan 02
2026
|
Alethia Young Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,289
-3.47%
|
$19,734
$6.8 P/Share
|
|
Jan 02
2026
|
Alethia Young Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+34.55%
|
-
|
|
Jan 02
2026
|
Alistair Milnes CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
3,244
-2.26%
|
$19,464
$6.8 P/Share
|
|
Jan 02
2026
|
Alistair Milnes CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+25.86%
|
-
|
|
Jan 02
2026
|
Michael Charles Ferguson Hannay CHIEF PROD & SUPPLY CHAIN OFF |
SELL
Open market or private sale
|
Direct |
2,827
-2.74%
|
$16,962
$6.8 P/Share
|
|
Jan 02
2026
|
Michael Charles Ferguson Hannay CHIEF PROD & SUPPLY CHAIN OFF |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+32.66%
|
-
|
|
Jan 02
2026
|
Michael Skynner CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct |
3,045
-1.81%
|
$18,270
$6.8 P/Share
|
|
Jan 02
2026
|
Michael Skynner CHIEF TECHNOLOGY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+22.91%
|
-
|
|
Jan 02
2026
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,317
-1.92%
|
$7,902
$6.8 P/Share
|
|
Jan 02
2026
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+35.31%
|
-
|
|
Jan 02
2026
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
38,000
+1.09%
|
-
|